Fig. 1From: From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical modelsSchematic representation of PREME. NB neuroblastoma, IHC immunohistochemistry, FCM flow cytometry, PDX Patient-Derived Xenograft, CDPX Cell Patient-Derived Xenograft, 3D patient-derived tumor-spheresBack to article page